Novo Nordisk: Leading the fight against diabetes through innovative research
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, with production facilities in nine countries and affiliates in five others. Controlled by majority shareholder Novo Holdings A/S, which holds approximately 28% of its shares and 77% of…
Gilead Sciences, Inc.: Pioneering Antiviral Therapies for Global Health
Gilead Sciences, Inc., founded on June 22, 1987, in Foster City, California, is a leading American biopharmaceutical company dedicated to researching and developing innovative antiviral drugs. With a focus on critical health issues, Gilead specializes in treatments for HIV/AIDS, hepatitis…
AbbVie’s $50B R&D Journey: Innovation & Dedication to Patients
In the world of biopharmaceuticals, few endeavors are as challenging, risky, or rewarding as research and development (R&D). For AbbVie, a global leader in the industry, R&D is not just a function of the business—it is the heart and soul…